Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > 06160 BeiGene, Ltd. > Detailed Quotes

06160 BeiGene, Ltd.

85.750
+2.250+2.69%
Extended Morning Session 09/29 11:59 CCT
High
87.150
Open
85.250
Turnover
10.28M
Low
85.100
Pre Close
83.500
Volume
119.40K
Market Cap
115.52B
P/E(TTM)
Loss
52wk High
239.600
Shares
1.35B
P/E(Static)
Loss
52wk Low
73.800
Float Cap
105.66B
Bid/Ask %
40.45%
Historical High
278.600
Shs Float
1.23B
Volume Ratio
0.27
Historical Low
61.050
Dividend TTM
--
Div Yield TTM
--
P/B
2.78
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.01%
Amplitude
2.46%
Avg Price
86.114
Lot Size
100
Float Cap
105.66B
Bid/Ask %
40.45%
Historical High
278.600
Shs Float
1.23B
Volume Ratio
0.27
Historical Low
61.050
Dividend TTM
--
P/B
2.78
Dividend LFY
--
Turnover Ratio
0.01%
Amplitude
2.46%
Avg Price
86.114
Lot Size
100
Price Forecast

No Data

News

Comment

Company Overview More
BeiGene Co., Ltd. is a global biotechnology company. The company focuses on discovering, developing, manufacturing and commercializing drugs to improve treatment effectiveness and expand access to patients around the world. The company has discovered and developed three approved drugs, including BRUKINSA, a small molecule inhibitor of Bruton tyrosine kinase (BTK) for the treatment of various blood cancers, tislelizumab for anti-PD-1 antibody immunotherapy for a variety of solid tumors and blood cancers, and pamiparib, a selective small molecule inhibitor for poly ADP ribose polymerase 1 (PARP1) and PARP2. The company also has other clinical products, including BGB-283, BGB-3245, BGB-11417, BGB-A445, BGB-A425, BGB-15025, BGB-A333, BGB-A1217 and BGB-10188. The company has offices in about 30 countries on five continents, including the United States, China, Europe and Australia.
CEO: Leiqiang Ou
Market: Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...